Genetron
liver cancer early screening tests development plan | Genetron
Company
Deck Type
Sector
Industry
Deck date
June 2022
Slide
6 of 29
Related slides by other companies
DiaCarta
SPAC
October 2022
well positioned for growth in the cancer market tests tests tests technology higher sensitivity faster scalable | DiaCarta
Mainz Biomed NV
Investor Presentation
December 2023
pipeline development | Mainz Biomed NV
Alkermes
Investor Presentation
October 2023
focused on initial potentially registrational indications with compelling expansion opportunities | Alkermes
Perspectum
IPO
July 2021
superior test for identifying nash patients treat for liver or liver | Perspectum
Other recent decks by Genetron
See all presentations (5 decks)
Results
August 2021
Results
May 2021
Results
April 2021
IPO
July 2020
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights